The Cellular Function Core (Core C) is designed to provide cutting-edge technology and standardized methodology to facilitate the experimentation of the projects and exchange of data. The facility consists of four technical components: 1) Microscopy, 2) Cellular assays, and 3) Altered gene.expression (adenoviral vector propagation). This Core is the continuation of our existing Gene Analysis Core (Core D in the previous PPG), with significant reconstitution to incorporate the latest technology arid methodology. We have now expanded our imaging capability with the inclusion of a Leica confocal microscope and a Zeiss NLO Multi-Photon System, and with techniques and methodology specifically tailored to the three research projects now proposed. In addition, the Core provides state-of- the-art technology developed on site, such as 3-D culture analysis, matrix manipulation, morphometrics, and microangiography, which will be invaluable for all projects. This Core will also provide space, facilities,supervision, and training for investigators who utilize morphological and computer analytical methodology to answer the basic questions proposed in the individual projects. Project investigators will have access to core facilities to run their own experiments and will be assisted by core director and technical staff concerning experimental design, technical expertise, and data interpretation to best utilize facilities and instrumentation. We project that this Core facility will be utilized by ALL THREE PROJECTS to the fullest extent.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA078582-10
Application #
7803627
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
10
Fiscal Year
2009
Total Cost
$161,615
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Scheiber, Melissa N; Watson, Patricia M; Rumboldt, Tihana et al. (2014) FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia 16:801-13
Kornblau, Steven M; Qiu, Yi Hua; Zhang, Nianxiang et al. (2011) Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood 118:5604-12
Turner, David P; Findlay, Victoria J; Moussa, Omar et al. (2011) Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate 71:1723-35
Markiewicz, Margaret; Nakerakanti, Sashidhar S; Kapanadze, Bagrat et al. (2011) Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. Microcirculation 18:1-11
Findlay, Victoria J; Turner, David P; Yordy, John S et al. (2011) Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. Genes Cancer 2:120-9
Duchi, Serena; Fagnocchi, Luca; Cavaliere, Valeria et al. (2010) Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability. Development 137:1493-503
Asano, Yoshihide; Stawski, Lukasz; Hant, Faye et al. (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176:1983-98
Moussa, Omar; LaRue, Amanda C; Abangan Jr, Romeo S et al. (2010) Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol 30:5194-206
Elkareh, Jihad; Periyasamy, Sankaridrug M; Shidyak, Amjad et al. (2009) Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol 296:F1219-26
Shirai, Keisuke; Sera, Yasuhiko; Bulkeley, William et al. (2009) Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia. Exp Hematol 37:1464-71

Showing the most recent 10 out of 84 publications